We partner with healthcare companies at every stage, delivering tailored strategic and transactional advisory.
Sell-side, buy-side and transaction advisory across the global healthcare ecosystem. We design and manage disciplined processes focused on value maximisation and execution certainty.
A unique combination of scientific depth, strategic networks and institutional-grade execution; purpose-built for healthcare companies.
Advanced medical and scientific training enables the rigorous assessment of complex technologies and the crafting of clear, differentiated equity stories that resonate with specialist investors and strategic partners.
A curated global network of leading healthcare-focused investors, pharma and medtech corporates, and strategic acquirers worldwide. Developed through years of active involvement in the sector, it provides direct access to the right counterparties and ensures focused, relevant engagement.
The rigour and standards developed over decades within top-tier investment banks, combined with the flexibility and hands-on dedication. Every process is conducted with discipline, discretion and a strong focus on outcomes.
Dedicated expertise across the healthcare ecosystem, from early-stage scientific platforms to scaled commercial organisations.

Novel therapeutic modalities, including biologics, gene and cell therapies, RNA-based treatments and advanced scientific platforms.

Branded, specialty and generic medicines across development and commercial portfolios.

Medical technologies, including robotic systems, clinical equipment, diagnostic devices and implantable solutions.

Software, artificial intelligence and data-driven healthcare platforms.

Provider networks, CROs, CDMOs and integrated healthcare service platforms.

Over-the-counter medicines, dietary supplements and other consumer health products.
A structured and disciplined approach applied to every mandate, designed to maximise outcomes while ensuring clarity, alignment, and efficiency at every stage.
In-depth analysis of positioning, technology, pipeline, competitive landscape and transaction objectives to identify key value drivers and determine the optimal transaction approach.
Development of a compelling equity story, detailed business plan and comprehensive financial analyses, together with the preparation of high-quality marketing materials and a fully organised data room.
Identification and confidential engagement of the most relevant strategic acquirers, financial investors or strategic partners.
End-to-end coordination of due diligence, Q&A sessions and advisor interactions to maintain alignment and execution momentum.
Negotiation of final terms and coordination of closing mechanisms through to signature and completion.
Reach out to explore how we can help you achieve your strategic objectives.